Understanding the NETest Results

NETesting is intended to aid in the identification of neuroendocrine tumor disease activity.

The NETest is a panel that targets 51 genes that are both informative about the biology of the tumor as well as can be used for normalization and quality control. The results from the gene expression data are used in the calculation of the NETest score – a percentage ranging from 0 to 100%.

The NETest Report (sample below) is delivered to your treating physician, who will interpret the results with your clinical assessment and other test results.